Literature DB >> 10955506

A precolumn derivatization high-performance liquid chromatographic method with improved sensitivity and specificity for the determination of astragaloside IV in Radix Astragali.

M Yao1, Y Qi, K Bi, X Wang, X Luo, C Che.   

Abstract

A reversed-phase high-performance liquid chromatographic method is developed for the determination of astragaloside (AGS) IV, which is known as the active constituent of Radix Astragali. The method uses precolumn derivatization with benzoyl chloride to form the benzoyl ester of AGS IV quantitatively and is carried out with a wide-ranging concentration (0.004-0.080 mg/mL) of the derivatized AGS IV. The eluent consists of 90% methanol, 4% tetrahydrofuran, 6% water, and 0.2% triethylamine, with vitamin D3 added as the internal standard.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955506     DOI: 10.1093/chromsci/38.8.325

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  4 in total

1.  Pharmacokinetics of Astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometry.

Authors:  Y Du; Q Zhang; G G Chen; P Wei; C Y Tu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

2.  High-throughput analysis and characterization of Astragalus membranaceus transcriptome using 454 GS FLX.

Authors:  Xiu-Bo Liu; Ling Ma; Ai-Hua Zhang; Yan-He Zhang; Jing Jiang; Wei Ma; Lei-Ming Zhang; Wei-Chao Ren; Xiang-Jun Kong
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

3.  Novel, Precise, Accurate Ion-Pairing Method to Determine the Related Substances of the Fondaparinux Sodium Drug Substance: Low-Molecular-Weight Heparin.

Authors:  Amol A Deshpande; P Madhavan; Girish R Deshpande; Ravi Kumar Chandel; Kaviraj M Yarbagi; Alok R Joshi; J Moses Babu; R Murali Krishna; I M Rao
Journal:  Sci Pharm       Date:  2015-07-22

4.  Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.

Authors:  Chenglai Xia; Zhihong He; Yantao Cai
Journal:  Cell Mol Biol Lett       Date:  2020-03-31       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.